Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: New Appointments at BD, Adaptive Biotechnologies, ChromaCode, More

Becton Dickinson: Christopher DelOrefice, Christopher Reidy 

Becton Dickinson has named Christopher DelOrefice to be the firm's executive vice president and chief financial officer, effective Sept. 6. DelOrefice will succeed Christopher Reidy, who had served as BD's CFO for eight years. He joins the firm from Johnson & Johnson, where he was most recently vice president of investor relations and also served as CFO of J&J's consumer and medical devices segments among other finance positions. Reidy will now become a director of the company formed in connection with the separation of the BD diabetes care business into an independent, publicly traded company.

Adaptive Biotechnologies: Nitin Sood 

Adaptive Biotechnologies has appointed Nitin Sood to the newly created position of chief commercial officer. Sood has more than 15 years of experience at life sciences and diagnostics companies, most recently at Guardant Health, where he was senior VP of product development. In his new role, he will oversee sales and marketing of Adaptive's immunoSEQ, clonoSEQ, and T-Detect products. Prior to joining Guardant, Sood was CEO of next-generation sequencing sample prep firm NuGEN. He also previously held roles at PerkinElmer and Agilent Technologies.

ChromaCode: Patrick Balthrop, Kevin O’Boyle

Patrick Balthrop and Kevin O’Boyle have joined the board of directors of molecular diagnostics developer ChromaCode. Balthrop is the former CEO and president of Luminex. He is also chairman of the board at Agendia; chairman of Discovery Life Sciences; and a founding principal of Apalachee Ventures. O’Boyle was most recently chairman of the board at GenMark Diagnostics, which was acquired by Roche in March. He is also currently a member of the board of directors at Nevro and Sientra.

For additional recent items on executive appointments and promotions in omics and molecular diagnostics, please see the People in the News page on our website. 

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.